C. Ardouin, V. Voon, Y. Worbe, N. Abouazar, V. Czernecki et al., Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation, Movement Disorders, vol.22, issue.11, pp.1941-1947, 2006.
DOI : 10.1002/mds.21098

A. Barbeau, Dopa therapy in Parkinsons disease: a critical review of nine years experience, Can Med Ass J, vol.101, pp.791-800, 1969.

P. Barone, W. Poewe, S. Albrecht, C. Debieuvre, D. Massey et al., Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial, The Lancet Neurology, vol.9, issue.6, 2010.
DOI : 10.1016/S1474-4422(10)70106-X

V. Czernecki, M. Schupbach, S. Yaici, R. Levy, E. Bardinet et al., Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom, Movement Disorders, vol.172, issue.7, pp.964-973, 2008.
DOI : 10.1002/mds.21949

URL : https://hal.archives-ouvertes.fr/hal-00805452

A. Evans, A. Lawrence, S. Cresswell, R. Katzenschlager, and A. Lees, Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti-reward, Movement Disorders, vol.69, issue.Suppl 1, pp.867-76, 2010.
DOI : 10.1002/mds.22898

A. Evans, N. Pavese, A. Lawrence, Y. Tai, S. Appel et al., Compulsive drug use linked to sensitized ventral striatal dopamine transmission, Annals of Neurology, vol.8, issue.5, pp.852-860, 2006.
DOI : 10.1002/ana.20822

S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph et al., Levodopa and the progression of Parkinson's disease, N Engl J Med, vol.351, pp.2547-2556, 2004.

J. Friedman, S. Feinberg, and R. Feldman, A Neuroleptic Malignantlike Syndrome due to Levodopa Therapy Withdrawal, JAMA: The Journal of the American Medical Association, vol.254, issue.19, pp.2792-2797, 1985.
DOI : 10.1001/jama.1985.03360190098033

A. Funkiewiez, C. Ardouin, E. Caputo, P. Krack, V. Fraix et al., Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.75, issue.6, pp.834-843, 2004.
DOI : 10.1136/jnnp.2002.009803

A. Funkiewiez, C. Ardouin, P. Krack, V. Fraix, N. Vanblercom et al., Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease, Movement Disorders, vol.15, issue.5, pp.524-554, 2003.
DOI : 10.1002/mds.10441

O. Guillin, J. Diaz, P. Carroll, N. Griffon, J. Schwartz et al., BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization, Nature, vol.411, issue.6833, pp.86-95, 2001.
DOI : 10.1038/35075076

J. Houeto, V. Mesnage, L. Mallet, B. Pillon, M. Gargiulo et al., Behavioural disorders, Parkinson's disease and subthalamic stimulation, Journal of Neurology, Neurosurgery & Psychiatry, vol.72, issue.6, pp.701-708, 2002.
DOI : 10.1136/jnnp.72.6.701

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737905

P. Krack, V. Fraix, A. Mendes, A. Benabid, and P. Pollak, Postoperative management of subthalamic nucleus stimulation for Parkinson's disease, Movement Disorders, vol.13, issue.S3, pp.188-97, 2002.
DOI : 10.1002/mds.10163

A. Lawrence, A. Evans, and A. Lees, Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?, The Lancet Neurology, vol.2, issue.10, pp.595-604, 2003.
DOI : 10.1016/S1474-4422(03)00529-5

S. Lim, O. Sullivan, S. Kotschet, K. Gallagher, D. Lacey et al., Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson???s disease, Journal of Clinical Neuroscience, vol.16, issue.9, pp.1148-52, 2009.
DOI : 10.1016/j.jocn.2008.12.010

R. Maricle, J. Nutt, R. Valentine, and J. Carter, Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: A double-blind, placebo-controlled study, Neurology, vol.45, issue.9, pp.1757-60, 1995.
DOI : 10.1212/WNL.45.9.1757

J. Montastruc, O. Rascol, J. Senard, and A. Rascol, A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.9, pp.1034-1042, 1994.
DOI : 10.1136/jnnp.57.9.1034

A. Murray, H. Ryoo, E. Gurevich, and J. Joyce, Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain., Proceedings of the National Academy of Sciences, vol.91, issue.23, pp.11271-11276, 1994.
DOI : 10.1073/pnas.91.23.11271

M. Nirenberg, Dopamine agonist withdrawal syndrome and non-motor symptoms after Parksinon's disease surgery. Letter to the editor, Brain, 2010.
DOI : 10.1093/brain/awq165

URL : http://doi.org/10.1093/brain/awq165

C. Olanow, R. Watts, and W. Koller, An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment, Neurology, vol.56, issue.Supplement 5, pp.1-88, 2001.
DOI : 10.1212/WNL.56.suppl_5.S1

C. Rabinak and M. Nirenberg, Dopamine Agonist Withdrawal Syndrome in Parkinson Disease, Archives of Neurology, vol.67, issue.1, pp.58-63, 2010.
DOI : 10.1001/archneurol.2009.294

F. Raudino, Non motor off in Parkinson's disease, Acta Neurologica Scandinavica, vol.1, issue.5, pp.312-317, 2001.
DOI : 10.1136/jnnp.68.4.429

O. Sacks, . Awakenings, H. London-smeding, A. Goudriaan, E. Foncke et al., Pan Books Ltd Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease, J Neurol Neurosurg Psychiatry, vol.78, pp.517-526, 1982.

S. Thobois, C. Ardouin, E. Lhommé-e, H. Klinger, C. Lagrange et al., Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation, Brain, vol.133, issue.4, pp.1111-1113, 2010.
DOI : 10.1093/brain/awq032

S. Thobois, S. Corvasier, P. Mertens, C. Diguardo, H. Mollion et al., The Timing of Antiparkinsonian Treatment Reduction after Subthalamic Nucleus Stimulation, European Neurology, vol.49, issue.1, pp.59-63, 2003.
DOI : 10.1159/000067028

V. Voon, K. Hassan, M. Zurowski, M. De-souza, T. Thomsen et al., Prevalence of repetitive and reward-seeking behaviors in Parkinson disease, Neurology, vol.67, issue.7, pp.1254-1261, 2006.
DOI : 10.1212/01.wnl.0000238503.20816.13

V. Voon, P. Krack, A. Lang, A. Lozano, K. Dujardin et al., A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease, Brain, vol.131, issue.10, pp.2720-2728, 2008.
DOI : 10.1093/brain/awn214

D. Weintraub, Dopamine and impulse control disorders in Parkinson's disease, Annals of Neurology, vol.164, issue.suppl 9, pp.93-100, 2008.
DOI : 10.1002/ana.21454

T. Witjas, C. Baunez, J. Henry, M. Delfini, J. Regis et al., Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation, Movement Disorders, vol.345, issue.8, pp.1052-1057, 2005.
DOI : 10.1002/mds.20501

T. Witjas, E. Kaphan, J. Azulay, O. Blin, M. Ceccaldi et al., Nonmotor fluctuations in Parkinson's disease: Frequent and disabling, Neurology, vol.59, issue.3, pp.408-421, 2002.
DOI : 10.1212/WNL.59.3.408

M. Yahr, R. Duvoisin, M. Schear, E. Barrett, and M. Hoehn, Treatment of Parkinsonism With Levodopa, Archives of Neurology, vol.21, issue.4, pp.343-54, 1969.
DOI : 10.1001/archneur.1969.00480160015001